echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Ma Yun: from medical representative to the richest man in China

    Ma Yun: from medical representative to the richest man in China

    • Last Update: 2014-09-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: 2014-09-23.18 billion US dollars financing of Chinese drugstores, up 38.07% on the first day Alibaba's listing once again demonstrates a myth of wealth creation Ma's worth also reached US $21.212 billion, surpassing Wang Jianlin and Ma Huateng as the new richest man in mainland China In the industry, "Ma Yun has a medical dream" has long been around The launch of tmall medical center in 2012 is just the beginning On January 23 this year, Alibaba announced its holding of CITIC 21st century, and Ma Yun took an important step to realize his medical dream It is widely believed that this will become a giant in the industry In fact, Ma Yun's medical plot and attitude are not laymen in the medical circle He should be said to be an old-fashioned medicine maker Even before Ma Yun founded Alibaba, in 1994, Haibo translation agency, the first translation company officially registered with Hangzhou Administration of industry and commerce, established Haibo, a transliteration of hope in English In addition, he also sells drugs and stocks But we don't know the details of Ma Yun's selling medicine, but we should make sure that he is the "older generation of drug makers" Ma Yun expressed his intention of investing in the pharmaceutical industry, using his consistent height: "Alibaba is not an ordinary commercial company, we believe that the Internet should not only be used to make money, it should promote social progress, change society and influence society, which is what our company has done Our fun is not how much money we earn, but because of us, society has changed a lot, because of us, top-down reform and promoting social progress and development have changed, which is our greatest fun It's more important to change because of us Recently, some people also said that you will be engaged in medicine and cultural industry In fact, we have a very clear idea What will happen to China in ten years? We believe that there are still two problems in China ten years later, one is the physical problem, the other is the ideological problem Today's physical problems, because of our haze today, because of our water, because of our food, ten years later, Chinese people will have a lot of diseases, how do we work on medicine today, because big data is to eliminate more drugs, make hospitals less and less, make hospitals quality better and better, make medicine quality better and better, and make medicine price cheaper and cheaper Not that we can sell medicine on Taobao today Ma also told Guo Guangchang, chairman of Fosun Group, at the annual conference of Chinese entrepreneurs in Yabuli in February, "sell less medicine and make more environment." Ma Yun's medical layout Ma Yun not only invested in CITIC in the 21st century, but also laid out the future hospital, but the future hospital should not be Ma Yun's kill in the pharmaceutical industry Zhang Jiangang, the head of the "future hospital" plan, told reporters that "Alipay has no ambition to overturn or rebuild medical care." We hope that through the intervention and output of Alipay, we can improve the efficiency of medical services as far as possible and provide convenience for patients and hospitals Obviously, Ma Yun not only wants to sell drugs on Taobao, but also uses big data to make the pharmaceutical industry more transparent and fair, forcing medical institutions and manufacturing enterprises to improve products and services and improve the health problems of Chinese people Once big data is combined with medical e-commerce, the life of Gedi's traditional pharmacies may even be the life of pharmaceutical distribution enterprises and medical institutions It's not impossible, because the medicine e-commerce through prescription medicine and medical insurance will change the lives of middlemen and traditional terminals, and the mobile medicine in the era of big data can replace the traditional medicine in the future The third-party drug trading platform 95095 controlled by CITIC 21st century is registered in Hebei, and Ma Yun's medical dream may set sail in Hebei In fact, Ma Yun's big move has not been noticed by the outside world: on June 27 this year, the Alibaba management team of Ma Yun's own team signed a strategic cooperation framework agreement with the Hebei provincial government in Shijiazhuang Alibaba will build a "smart Hebei" based on cloud computing, big data and digital Internet in Hebei In the strategic cooperation framework agreement, there are eight key cooperation, and intelligent drug supervision is the top priority According to the agreement, the information management system of "intelligent drug administration" includes Alibaba's cooperation with Hebei to build a comprehensive business platform covering the safety supervision of drugs, cosmetics, health food and medical devices; the application demonstration of big data of drug administration based on cloud computing, focusing on the electronic supervision of drugs, and the electronic supervision of drugs (vaccines) of China's drug administration network and medical institutions Network and Shijiazhuang medical insurance drug monitoring and prescription electronic cloud pilot experience gradually spread to the whole province "In the future, the data of Hebei's medicine, medical insurance and medical treatment will be gradually opened up With the electronic prescription, people can compare the prices of drugs on the Internet, realize the mobile intelligent medical treatment, and even monitor the medical insurance funds The medical industry will be transparent." Zhang Yong, Alibaba's chief operating officer, described the possible medical treatment ways for Hebei people in the future with the help of cloud computing for Zhou benshun, Secretary of the CPC Hebei Provincial Committee and director of the Standing Committee of the provincial people's Congress In Alibaba's large strategic division of medicine e-commerce, tmall medical center is responsible for the operation of over-the-counter drugs and medical devices, and Ali health is responsible for the operation of prescription drugs According to people familiar with the matter, although the new Internet drug regulations are still in the pipeline, Ali has taken the lead in obtaining the pilot approval for Internet sales of prescription drugs Currently, Alibaba is piloting an e-prescription drug platform through Alibaba health information technology company (formerly CITIC 21st century Co., Ltd., hereinafter referred to as Alibaba Health) In today's medical policy environment, Ali's idea seems to people in the circle to be wishful thinking There are many pain points to be solved in making prescription drug e-commerce: where does the prescription come from? Will the hospital give you a prescription? How to solve the problem of medical insurance? "Ali dares to be a promoter of the pharmaceutical industry We, the industry leaders, dare not move and take the lead in opposing Only people like Ma Yun can promote social progress " A pharmaceutical industry boss said he was optimistic about Ma Yun  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.